Leukotriene B4 pathway regulates the fate of the hematopoietic stem cells.
- Author:
Jin Woong CHUNG
1
;
Geun Young KIM
;
Yeung Chul MUN
;
Ji Young AHN
;
Chu Myong SEONG
;
Jae Hong KIM
Author Information
1. School of Life Sciences and Biotechnology, Korea University, Seoul, Korea. jhongkim@korea.ac.kr
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
BLT2;
CD34;
apoptosis;
cell differentiation;
hematopoietic stem cells;
leukotriene B4;
receptors
- MeSH:
Antigens, CD34/metabolism;
Apoptosis/drug effects;
Cell Differentiation/drug effects;
Cell Proliferation/drug effects;
Fetal Blood/cytology/drug effects;
Hematopoietic Stem Cells/*drug effects/metabolism;
Humans;
Leukotriene B4/*pharmacology;
Receptors, Leukotriene B4/genetics/metabolism;
Research Support, Non-U.S. Gov't;
Reverse Transcriptase Polymerase Chain Reaction;
*Signal Transduction
- From:Experimental & Molecular Medicine
2005;37(1):45-50
- CountryRepublic of Korea
- Language:English
-
Abstract:
Leukotriene B4(LTB4), derived from arachidonic acid, is a potent chemotactic agent and activating factor for hematopoietic cells. In addition to host defense in vivo, several eicosanoids have been reported to be involved in stem cell differentiation or proliferation. In this study, we investigated the effect of LTB4 on human cord blood CD34+ hematopoietic stem cells (HSCs). LTB4 was shown to induce proliferation of HSC and exert anti-apoptotic effect on the stem cells. Blockade of interaction between LTB4 and its receptor enhanced self-renewal of the stem cells. Effect of LTB4 on differentiation of CD34+ HSCs were confirmed by clonogenic assays, and induction of the expression of BLT2 (the low- affinity LTB4 receptor), during the ex vivo expansion was confirmed by reverse transcription-PCR. Our results suggest that LTB4-BLT2 interaction is involved in the cytokine-induced differentiation and ex vivo expansion of hematopoietic stem cells.
